Evolution of the reagent market: how sensitivity demands and miniaturization shape the future
Lately I’ve noticed that almost every grant proposal or project pitch I’m involved with asks about sensitivity levels that would’ve been unthinkable five years ago. On top of that, everyone wants assays to be faster, smaller, and easier to use, almost like point-of-care devices. I remember running older ELISA plates where time wasn’t the biggest concern, but now the expectation is ultra-sensitive results in record time. How do you see this trend affecting what’s available in the market?
1 View